NUMIF (Numinus Wellness) EV-to-EBIT: -1.16 (As of Jul. 10, 2026)


What is Numinus Wellness EV-to-EBIT?

Numinus Wellness NUMIF +0.33% EV-to-EBIT is -1.16 as of Jul. 10, 2026.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Numinus Wellness's Enterprise Value is $10.71 Mil. Numinus Wellness's EBIT for the trailing twelve months (TTM) ended in May. 2025 was $-9.24 Mil. Therefore, Numinus Wellness's EV-to-EBIT for today is -1.16.

The historical rank and industry rank for Numinus Wellness's EV-to-EBIT or its related term are showing as below:

NUMIF' s EV-to-EBIT Range Over the Past 10 Years
Min: -1.5   Med: 0   Max: 0
Current: -1.16

NUMIF's EV-to-EBIT is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 15.7 vs NUMIF: -1.16

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Numinus Wellness's Enterprise Value for the quarter that ended in May. 2025 was $8.95 Mil. Numinus Wellness's EBIT for the trailing twelve months (TTM) ended in May. 2025 was $-9.24 Mil. Numinus Wellness's Earnings Yield (Joel Greenblatt) % for the quarter that ended in May. 2025 was -103.15%.


Numinus Wellness  (OTCPK:NUMIF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Numinus Wellness's Earnings Yield (Joel Greenblatt) % for the quarter that ended in May. 2025 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: May. 2025 ) =EBIT / Enterprise Value (Q: May. 2025 )
=-9.235/8.9525516
=-103.15 %

Numinus Wellness's Enterprise Value for the quarter that ended in May. 2025 was $8.95 Mil.
Numinus Wellness's EBIT for the trailing twelve months (TTM) ended in May. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-9.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Numinus Wellness EV-to-EBIT Related Terms


Numinus Wellness EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Numinus Wellness's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Numinus Wellness EV-to-EBIT Chart

Numinus Wellness Annual Data
Trend Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
EV-to-EBIT
Get a 7-Day Free Trial -2.25 -6.16 -1.51 -2.19 -0.78

Numinus Wellness Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.49 -0.78 -1.54 -1.10 -1.34

NUMIF vs HLYK, SYRA, GBCS: EV-to-EBIT Comparison

For the Medical Care Facilities subindustry, Numinus Wellness's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Numinus Wellness EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Numinus Wellness's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Numinus Wellness's EV-to-EBIT falls into.



Numinus Wellness EV-to-EBIT Calculation

Numinus Wellness's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=10.706/-9.235
=-1.16

Numinus Wellness's current Enterprise Value is $10.71 Mil.
Numinus Wellness's EBIT for the trailing twelve months (TTM) ended in May. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-9.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-EBIT →
What does a EV-to-EBIT of -1.16 mean?
Numinus Wellness (NUMIF) has a EV-to-EBIT of -1.16 as of Jul. 10, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Numinus Wellness and its competitors.
Is Numinus Wellness' EV-to-EBIT too high?
Numinus Wellness' current EV-to-EBIT is -1.16.
How does Numinus Wellness' EV-to-EBIT compare to HLYK and SYRA?
Numinus Wellness' EV-to-EBIT of -1.16 can be compared against companies in the Healthcare Providers & Services industry. The industry median EV-to-EBIT is 15.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.70, based on 469 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Numinus Wellness and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Numinus Wellness's current EV-to-EBIT is -1.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Numinus Wellness stock overvalued right now?
Numinus Wellness (NUMIF) has a current EV-to-EBIT of -1.16. The current EV-to-EBIT is -1.16. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Numinus Wellness (NUMIF), the current EV-to-EBIT is -1.16 as of Jul. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Numinus Wellness Business Description

Address 801 - 33 Water Street, Vancouver, BC, CAN, V6B 1R4
Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes. The company's clinic network consists of Numinus Health, Mindspace Services, and the Neurology Center of Toronto. Its services include Ketamine-assisted psychotherapy for depression, neurological care, psychotherapy, and counseling by registered psychologists among others. The company's operating segments are; Clinical research operations, Canadian clinic network, US clinic network and Corporate. The majority of the revenue for the company is generated from US clinic network segment. Geographically, the company has its presence in United States and Canada.